CIK 0001812364
- Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- 4 Open-market sale Senior Vice President, Finance sold 22,500 shares at $35.00 ($787,500)
- 4 Grant or award Bergstrom Donald A acquired 34,999 shares (grant or award)
- 4 Gift President and CEO gave 150,000 shares (gift)
- 4 Grant or award Senior Vice President, Finance acquired 15,870 shares (grant or award)
- 4 Grant or award General Counsel acquired 15,870 shares (grant or award)
- 4 Other acquisition Director acquired 28,538 shares (other)
- 4 Other acquisition Director acquired 30,194 shares (other)
- 4 Other acquisition Director acquired 70,956 shares (other)
- 4 Open-market sale General Counsel sold 5,000 shares at $55.05 ($275,250)
- 4 Open-market sale 10% owner sold 5,622,394 shares at an average $40.40 ($227,132,712)
- 4/A Insider Changes in Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Conversion 10% owner acquired 12,799,078 shares (conversion)
- 4 Conversion 10% owner acquired 27,904,963 shares (conversion)
- 4 Open-market buy President and CEO bought 25,000 shares at $20.00 ($500,000)
- 4 Open-market buy Director bought 25,000 shares at $20.00 ($500,000)
- 4 Open-market buy Director bought 25,000 shares at $20.00 ($500,000)
Page 15 of 16 · 320 filings